Yangzhenhua 851

MENU

Prostate-Specific Antigen Modulatory Effect of a Fermented Soy Supplement for Patients with an Elevated Risk of Prostate Cancer: a Non-Randomized, Retrospective Observational Registration

Time of issue：

2025-06-03 14:14

Previous

Fermented Soy Beverage Q-CAN Plus Consumption Improves Serum Cholesterol and Cytokines

Next

Effect of the Fermented Soy Q-CAN® Product on Biomarkers of Inflammation and Oxidation in Adults with Cardiovascular Risk, and Canonical Correlations between the Inflammation Biomarkers and Blood Lipids

Previous:

Fermented Soy Beverage Q-CAN Plus Consumption Improves Serum Cholesterol and Cytokines

Next:

Effect of the Fermented Soy Q-CAN® Product on Biomarkers of Inflammation and Oxidation in Adults with Cardiovascular Risk, and Canonical Correlations between the Inflammation Biomarkers and Blood Lipids

Categories

Categories

851 International Research

Recent posts

In October 2008, 851, the company also developed new products to improve the immunity and obtained the approval certificate

2021-02-24

Advising consumers

2021-02-24

Yang Zhenhua 851 Get 1000 Shanghai Cancer Rehabilitation Club free trial of patients signing ceremony in Yung

2021-02-24

Copyright © Fujian Yang Zhenhua 851 Bio-Science Co., Ltd Powered by www.300.cn

Business Licence SEO